Press releases
-
Recruitment of global Phase III clinical trial of ‘GBP510’ completed, with vaccine expected to be au...2022. 01. 18 -
The first approval of a recombinant protein nanoparticle COVID-19 vaccine with proven efficacy and s...2022. 01. 12 -
SK bioscience-Novavax Extend Collaboration and Contract Manufacturing Agreements of COVID-19 VaccineSK-Novavax amended the Collaboration and License agreement for contract manufacturing of ‘NVX-CoV237...2021. 12. 24 -
SK will develop a vaccine candidate against sarvecovirus- the group of viruses containing SARS-CoV ...2021. 12. 21 -
SK bioscience (CEO Jae-Yong Ahn) announced the promotion of new executives for 2022 on December 2nd...2021. 12. 2 -
SK bioscience will establish an industry-university partnership to preemptively respond to new vira...2021. 12. 2 -
SK, IVI sign an agreement to launch the “Park MahnHoon Award” to honor individuals and organizations...2021. 11. 30 -
The first submission of a protein-based COVID-19 vaccine candidate in KoreaHigh expectations of the ...2021. 11. 15 -
The final data of the phase I/II clinical trial confirms 3.6 to 6 folds of neutralizing antibody tit...2021. 11. 05 -
SK bioscience will continue production of global biopharmaceutical company´s COVID-19 vaccines next...2021. 10. 06